Organoids serve as viable in vitro model for functional precision medicine for mesonephric-like adenocarcinoma of the ovary
D Holthaus, Huy Duc Le, Laura Matzner, Franziska Kellers, Christoph Rogmans, Vincent Winkler, Lorenz Bastian, Stephanie M. J. Fliedner, Jörg Paul Weimer, Hauke S. Busch, Tim Mandelkow, Björn Konukiewitz, Nicolai Maass, Marion van Mackelenbergh, İbrahim Alkatout, , Nina Hedemann
The paper demonstrates that ovarian cancer organoids derived from mesonephric-like adenocarcinoma can be used for functional precision medicine, showing sensitivity to binimetinib and resistance to standard chemotherapeutics.
JCO Precision Oncology · Sep 1, 2026Peer-reviewedCancer Biology